Adverse events588

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 588

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Randomized Treatment Period: Vandetanib	6	117	7
other	Anaemia	Blood and lymphatic system disorders	Randomized Treatment Period: Placebo	6	118	8
other	Anaemia	Blood and lymphatic system disorders	Open-Label Treatment Period: Vandetanib/Vandetanib	1	23	1
other	Anaemia	Blood and lymphatic system disorders	Open-Label Treatment Period: Placebo/Vandetanib	0	74	0
other	Cornea Verticillata	Eye disorders	Randomized Treatment Period: Vandetanib	9	117	9
other	Cornea Verticillata	Eye disorders	Randomized Treatment Period: Placebo	0	118	0
other	Cornea Verticillata	Eye disorders	Open-Label Treatment Period: Vandetanib/Vandetanib	1	23	1
other	Cornea Verticillata	Eye disorders	Open-Label Treatment Period: Placebo/Vandetanib	4	74	4
other	Abdominal Pain	Gastrointestinal disorders	Randomized Treatment Period: Vandetanib	8	117	9
other	Abdominal Pain	Gastrointestinal disorders	Randomized Treatment Period: Placebo	8	118	9
other	Abdominal Pain	Gastrointestinal disorders	Open-Label Treatment Period: Vandetanib/Vandetanib	0	23	0
other	Abdominal Pain	Gastrointestinal disorders	Open-Label Treatment Period: Placebo/Vandetanib	3	74	3
other	Abdominal Pain Upper	Gastrointestinal disorders	Randomized Treatment Period: Vandetanib	6	117	9
other	Abdominal Pain Upper	Gastrointestinal disorders	Randomized Treatment Period: Placebo	4	118	4
other	Abdominal Pain Upper	Gastrointestinal disorders	Open-Label Treatment Period: Vandetanib/Vandetanib	1	23	1
other	Abdominal Pain Upper	Gastrointestinal disorders	Open-Label Treatment Period: Placebo/Vandetanib	6	74	6
other	Constipation	Gastrointestinal disorders	Randomized Treatment Period: Vandetanib	9	117	11
other	Constipation	Gastrointestinal disorders	Randomized Treatment Period: Placebo	11	118	13
other	Constipation	Gastrointestinal disorders	Open-Label Treatment Period: Vandetanib/Vandetanib	2	23	2
other	Constipation	Gastrointestinal disorders	Open-Label Treatment Period: Placebo/Vandetanib	1	74	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01876784/events

API reference For AI assistants

Adverse events588

Sources 3

Read this list from software.